Bill Rote
Chief Tech/Sci/R&D Officer chez TRAVERE THERAPEUTICS, INC.
Fortune : 622 351 $ au 31/03/2024
Profil
William E.
Rote is currently the Senior VP, Head-Research & Development at Travere Therapeutics, Inc. He previously worked as the Executive Director-Biologics Development at Corvas International, Inc. from 1993 to 2003, Vice President, Head-Research & Development at Amylin Pharmaceuticals, Inc. from 2007 to 2014, and Vice President-Clinical Development at Ardea Biosciences, Inc. from 2014 to 2016.
He also served as a Non-Executive Director at Xenome Ltd.
in 2009 and as the Chief Operating Officer at Psylin Neurosciences, Inc. He holds undergraduate and doctorate degrees from The Pennsylvania State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/02/2024 | 80 720 ( 0,11% ) | 622 351 $ | 31/03/2024 |
Postes actifs de Bill Rote
| Sociétés | Poste | Début |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/02/2017 |
Anciens postes connus de Bill Rote
| Sociétés | Poste | Fin |
|---|---|---|
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | 01/07/2016 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/07/2014 |
| Corvas International, Inc. | Corporate Officer/Principal | 01/01/2003 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Psylin Neurosciences, Inc.
 Psylin Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Psylin Neurosciences, Inc. discovers and develops peptide hormones for the treatment of psychiatric disorders. The firm is formed in partnership between Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. The company was founded on January 30, 2007 and is located in San Diego, CA | Chief Operating Officer | - |
Formation de Bill Rote
| The Pennsylvania State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
| Corvas International, Inc. | Health Technology |
Psylin Neurosciences, Inc.
Psylin Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Psylin Neurosciences, Inc. discovers and develops peptide hormones for the treatment of psychiatric disorders. The firm is formed in partnership between Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. The company was founded on January 30, 2007 and is located in San Diego, CA | Health Technology |
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Health Technology |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
